zeinabafshar710@gmail.com, fatemi_farahnaz@yahoo.com, f.mohaghegh199@gmail.com.
Key Clinical Message:
We presented the first case of AGEP following treatment with remdesivir in a patient with COVID-19 without hydroxychloroquine use which could be an important issue when dealing with cutaneous rashes, considering the widespread use of Remdesivir in COVID era.